全文获取类型
收费全文 | 23123篇 |
免费 | 1055篇 |
国内免费 | 141篇 |
专业分类
耳鼻咽喉 | 227篇 |
儿科学 | 419篇 |
妇产科学 | 465篇 |
基础医学 | 2965篇 |
口腔科学 | 474篇 |
临床医学 | 1456篇 |
内科学 | 5508篇 |
皮肤病学 | 322篇 |
神经病学 | 2244篇 |
特种医学 | 953篇 |
外科学 | 3920篇 |
综合类 | 83篇 |
一般理论 | 5篇 |
预防医学 | 729篇 |
眼科学 | 492篇 |
药学 | 1346篇 |
中国医学 | 23篇 |
肿瘤学 | 2688篇 |
出版年
2023年 | 101篇 |
2022年 | 234篇 |
2021年 | 497篇 |
2020年 | 273篇 |
2019年 | 351篇 |
2018年 | 437篇 |
2017年 | 340篇 |
2016年 | 393篇 |
2015年 | 440篇 |
2014年 | 563篇 |
2013年 | 743篇 |
2012年 | 1126篇 |
2011年 | 1140篇 |
2010年 | 632篇 |
2009年 | 579篇 |
2008年 | 898篇 |
2007年 | 1039篇 |
2006年 | 991篇 |
2005年 | 908篇 |
2004年 | 901篇 |
2003年 | 878篇 |
2002年 | 961篇 |
2001年 | 690篇 |
2000年 | 744篇 |
1999年 | 689篇 |
1998年 | 272篇 |
1997年 | 215篇 |
1996年 | 204篇 |
1995年 | 199篇 |
1994年 | 196篇 |
1993年 | 185篇 |
1992年 | 637篇 |
1991年 | 560篇 |
1990年 | 554篇 |
1989年 | 560篇 |
1988年 | 504篇 |
1987年 | 487篇 |
1986年 | 439篇 |
1985年 | 452篇 |
1984年 | 252篇 |
1983年 | 212篇 |
1979年 | 232篇 |
1978年 | 129篇 |
1977年 | 100篇 |
1975年 | 98篇 |
1974年 | 99篇 |
1973年 | 98篇 |
1970年 | 103篇 |
1969年 | 123篇 |
1968年 | 99篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Zhenzhen Zhang Mark Garzotto Tomasz M. Beer Philippe Thuillier Stephen Lieberman Motomi Mori 《Nutrition and cancer》2016,68(8):1309-1319
Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue. 相似文献
2.
3.
4.
Masaru Sasaki Tsuyoshi Takahashi Soichiro Funaki Koji Tanaka Yasuhiro Miyazaki Naoko Ose Tomoki Makino Yukinori Kurokawa Makoto Yamasaki Kiyokazu Nakajima Yasushi Shintani Masaki Mori Yuichiro Doki 《Asian journal of endoscopic surgery》2021,14(1):116-119
We report a case of a diaphragmatic hernia after a heart transplant operation. A 43-year-old woman, who underwent orthotropic heart transplantation for hypertrophic cadiomyopathy two year earlier, presented with vomiting and epigastric pain. A computed tomography scan showed that the stomach and transverse colon were dislocated in the left thoracic cavity. We diagnosed left diaphragmatic hernia incarceration and performed laparoscopic repair of the diaphragmatic hernia. A 12 × 8 cm diaphragmatic defect was found intraoperatively on the ventrolateral aspect of the left diaphragm, and the stomach with volvulus had herniated into the thorax through the defect. The hernia was considered to be iatrogenic. The diaphragmatic defect was large, and the diaphragm was thinning. We closed the defect by mesh repair. Laparoscopic mesh repair of the diaphragmatic hernia could be performed safely and with minimal invasiveness. 相似文献
5.
6.
7.
8.
9.
Maria Ricci Agostino Chiaravalloti Alessandro Martorana Giacomo Koch Vincenzo De lucia Gaetano Barbagallo Orazio Schillaci 《Annals of nuclear medicine》2020,34(4):254-262
The aim of our study was to investigate the impact of the epsilon phenotype in brain glucose consumption in a population with Alzheimer’s disease. Statistical Parametric Mapping (SPM8) was used to investigate differences in brain glucose consumption (as detectable by means of 18F FDG-PET/CT) in the population examined. A total of 129 patients (72 females and 57 males) with a diagnosis of probable AD according to the NINCDS-ADRDA criteria underwent the PET/CT examination. The mean (SD) age of the patients was 70 (± 7) years; the mean Mini-Mental State Examination was 19(± 5.6). 59 expressed epsilon 4 phenotype (E4) and 70 expressed the epsilon 3 phenotype (E3). Cerebral spinal fluid amyloid, tau, and t-tau have been measured resulting equal to 367.4 (± 149.1), 584.7 (± 312.1), and 79.2(± 45.9) pg/ml, respectively. Patients with confirmed amyloid and Tau changes were classified as AD. Patients with amyloid changes but negative Tau, considered as high risk of AD, were classified as IAD. Age, sex, MMSE, scholarship, and CSF parameters were used as a covariate in the SPM analyses. We did not find significant differences in age, gender, and MMSE and CSF parameters among groups. In the analysis of the AD group as compared to AD-E3, AD-E4 subjects show a significant reduction of brain glucose consumption in inferior frontal gyrus bilaterally (BA 45, BA 47). In the analysis of the IAD group as compared to IAD-E3, IAD-E4 subjects show a significant reduction of brain glucose consumption in right in medial, middle, and superior frontal gyrus (BA10, BA11), and in left medial and middle frontal gyrus (BA10, BA11). The differences between IAD-E3 and AD-E3 and between IAD-E4 and AD-E4 (and vice versa analysis) resulted not significant. APO-e4 is related to a major involvement of the frontal cortex confirming its role of risk factor in AD, while APO-3 seems not related to a specific pattern, supporting the hypothesis of neutral/protective role in AD. 相似文献
10.